Dr. Kyle MacLean, MD

Dr. MacLean practices at Lasercare Eye Center, P.a. in Lewisville, Texas.

Dr. MacLean's NPI, 1053706184, was assigned on April 6, 2015. Dr. MacLean graduated from University of Rochester Medical Center in 2014. Dr. MacLean holds Texas license S1447.

Dr. MacLean's primary practice is Lasercare Eye Center, P.a., at 402 State Rte 121 Bus, Lewisville, TX 75057. The practice phone is (214) 574-9600.

Dr. MacLean's primary practice is Lasercare Eye Center, P.a. in Lewisville, Texas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. MacLean to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. MacLean practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. MacLean's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. MacLean is board certified in ophthalmology by the American Board of Ophthalmology. Dr. MacLean is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. MacLean treats.

CMS data shows 850 Medicare services from Dr. MacLean across 10 procedure codes in 2024, for 319 Medicare patients. Medicare paid $60,735 for them.

CMS counts 319 Medicare patients who saw Dr. MacLean in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. MacLean's median patient age at 64, with 59% women.

In 2024, Dr. MacLean wrote 218 Medicare Part D claims for 85 patients. 56% of them were for generic drugs. CMS names the drug for 147 of them, across 6 drugs with 11 or more claims each, at $32,053 in total drug cost. In 2023, CMS named 114 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. MacLean for performance year 2024, reported as part of a group. Dr. MacLean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of cataract surgery by Dr. MacLean, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. MacLean, published from 2014 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Lenses, Intraocular, Phacoemulsification and Lens Implantation, Intraocular. Dr. MacLean has published most often in J Cataract Refract Surg. Dr. MacLean's most frequent co-authors are Nick Mamalis, MD, Iqbal Ahmed, MD and Sepehr Bahadorani, MD.

CMS Open Payments shows 49 general payments to Dr. MacLean from 13 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 95% of the total. Carl Zeiss Meditec USA, Inc. paid the most, $709.

Dmand AI lists 1 award for Dr. MacLean, most recently Advocacy Ambassador in 2019.

Dr. MacLean graduated from University of Rochester Medical Center in 2014. Dr. MacLean is a member of AAO, ASCRS and TMA.

Dr. MacLean is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.